The control of cell cycle progression is orchestrated by an extraordinary diverse and dynamic in function group of proteins. Critical in the progression are the actions of the E2F family of transcription factors which regulate the expression of genes necessary for the G 1 /S transition and the WAF/CIP/KIP family of cdk inhibitors which can inhibit cell cycle progression. In this report, we have identi®ed E2F binding sites in both the human and mouse p21 promoters that bind E2F protein complexes from nuclear extracts in a cell cycle-dependent manner. In ectopic expression experiments we determined that E2F1, but not E2F4, can strongly transactivate the human p21 gene through these E2F binding sites which are located in the 7215/+1 region of the p21 gene. The transactivation of the p21 gene through regulatory elements within the 7215/+1 region of the promoter was correlated with increased levels of endogenous E2F1 and p21 proteins at the G 1 /S boundary. The signi®cance of transactivation of the p21 gene by E2F is that p21 function is important in cell cycle progression as well as for cell cycle arrest. Indeed, E2F-induced levels of p21 protein during the G 1 / S transition is consistent with the recent ®ndings demonstrating that p21 acts as an assembly factor for kinase active cyclin/cdk/p21 complexes.
Introduction
The transcription factor E2F was ®rst discovered as a cellular DNA-binding activity responsible for activation of the adenovirus E2A promoter (Kovesdi et al., 1986; Yee et al., 1987) . Subsequent studies have shown that together with its heterodimeric partner DP (Girling et al., 1993; Helin et al., 1993a; Krek et al., 1993; Wu et al., 1995) ,`free' E2F confers cell cycle-speci®c expression to promoters containing E2F binding sites. E2F-mediated transcriptional activation is repressed through a physical association between E2F and proteins of the retinoblastoma family (pRB, p107, p130 collectively referred to as`pocket' proteins) (Helin et al., 1993b; Hiebert et al., 1992; Weintraub et al., 1992; Zamanian and La Thangue, 1993) . Five dierent E2Fs have been identi®ed where E2F1-3 interact preferentially with pRB, E2F4 with p107 and p130 (Beijersbergen et al., 1994; Ginsberg et al., 1994; Moberg et al., 1996; Vairo et al., 1995) , and E2F5 with p130 (Hijmans et al., 1995) . During cell cycle progression through the G 1 /S boundary, G 1 cyclins and their associated cyclin-dependent kinases cause a dissociation of the pocket protein/E2F complexes, and subsequent activation of E2F mediated transcription. Two classes of genes have been identi®ed that are stimulated by E2F binding activity. One class encodes proteins required for DNA synthesis, including dihydrofolate reductase (DHFR), thymidine kinase (TK), proliferating cell nuclear antigen (PCNA), and DNA polymerase (Farnham et al., 1993; Helin and Harlow, 1993; La Thangue, 1994; Nevins, 1992) . The other class encodes proteins that play a role in the G 1 /S transition, such as cyclin E, cyclin A, p107 and E2F1 itself (Botz et al., 1996; Degregori et al., 1995; Johnson et al., 1994; Neuman et al., 1994; Schulze et al., 1995; Zhu et al., 1995a) . These ®ndings indicate a regulatory link between the ability of a cell to enter S-phase and the appropriate activation of the E2F during G 1 -phase.
p21 had been shown to inhibit a wide variety of cyclin/cdk complexes including G 1 cyclin/cdk complexes, which is critical in the G 1 /S transition (Xiong et al., 1993) . Expression of the p21 gene is induced in a p53-dependent manner in response to DNA damage, resulting in G 1 /S arrest through inhibition of the cyclin/ cdk complexes (Dulic et al., 1994; El-Deiry et al., 1994) . p21 gene expression is also induced, through a p53-independent mechanism, following stimulation with serum or puri®ed growth factors (Liu et al., 1996; Macleod et al., 1995) , during dierentiation of a number of cell types in vitro (Halevy et al., 1995; Jiang et al., 1994; Parker et al., 1995) and in tissues during murine development (Macleod et al., 1995) . These results suggest that the physiological function of p21 is not limited to the execution of cell cycle-arrest program. Indeed, the majority of p21 protein is found in activated cyclin/cdk complexes present in proliferating cells (Zhang et al., 1994) . Moreover it has recently been shown that at low concentrations p21 promotes the assembly of stable cdk4 and D-type cyclin kinase active complexes, whereas at high concentrations it inhibits kinase activity .
We have shown in a previous study that overexpression of E2F1 and DP1 in human glioma U343 cells resulted in transactivation of a p21 promoter construct containing the 7215/+1 region of the human p21 gene (Hiyama et al., 1997) . We identi®ed a potential E2F binding sequence between 7155 and 7148 within the human promoter, that shares a high degree of similarity with the E2F recognition sequence (Nevins, 1992) . In this report, we have identi®ed several E2F binding sites in both the human and mouse p21 promoters, that bind recombinant E2F1 protein and E2F binding activity present in nuclear extracts from quiescent and cycling cells. In overexpression experiments we determined that E2F1, but not E2F4, could strongly transactivate the 7215/+1 region of the human p21 gene through two dierent E2F binding sites which we have designated E2F(a) and E2F(b). We also report here a regulatory link between E2F1 and p21 in cell cycle machinary.
Results

Identi®cation of potential E2F binding sites in the human and mouse p21 promoters
In addition to a potential E2F binding motif of 7155/ CTCCGCGC/7148 we have reported previously (Hiyama et al., 1997) , designated E2F(a), we identi®ed another motif of CGCGC, designated E2F(b), at three dierent positions (7103/799,789/785,736/732) within the human p21 promoter (Figure 1a, b) . In the mouse p21 promoter, we also identi®ed one E2F(b) and two additional potential E2F-binding motif of 7161/ TAACGCGC/7154, 7139/TCTGGCGC/7132, designated E2F(c) and E2F(d), respectively. GC-rich regions that conform to the binding site for Sp1 and consensus E-box sequences (CANNTG, where N is A, C, G or T) are also present in both the human and mouse p21 promoters ( Figure 1a ) (Prowse et al., 1997) .
Recombinant and nuclear extract-derived E2F protein can bind E2F(a), E2F(b) and E2F(c) sites
We ®rst con®rmed that recombinant E2F1 and DP1 protein (Dynlacht et al., 1994) were able to form (Figures 1b and 2 ). We next carried out competition experiments using nuclear extract from U343 human glioma cells (Figure 3a ). The binding of cellular proteins to either the E2F(a) or E2F(b) probe was competed out by cE2F, but not by mutated cE2F (mcE2F; Figure 3a ). In the reverse competition experiment, E2F binding activity for the cE2F probe was substantially reduced by a 100-fold molar excess of either E2F(a) or E2F(b), but not by a 100-fold molar excess of mutated E2F(a) or E2F(b) [mE2F(a), mE2F(b)]. Two DNA-protein complexes in addition to the`free' E2F were observed. The slowest migration band (*) represents an E2F4 protein-DNA complex based on the ability of anti-E2F4 antibody to supershift the complex (data not shown). The other band (**) likely represents a Yi protein-DNA complex, because of the similarity with the sequence CGCCCTTTCT, which occurs in all of the probes, to the Yi recognition sequence (CCCNCNNNCT) (Dou et al., 1991) . We also con®rmed that the DNA-protein complex that occurred with the E2F(c) probe and nuclear extract from NIH3T3 was competed out by cE2F, but not by mcE2F ( Figure 3b ). Similarly, in the reverse competition experiments, using labeled cE2F as a probe, 10-and 100-fold molar excess of E2F(c), but not mutated E2F(c) [mE2F(c)], essentially abolished formation of the complex. E2F4 was found to be a component of the observed`free' E2F in supershift experiments using antibody to E2F4 (data not shown).
Binding of E2F proteins to E2F(a) and E2F(b) sites is cell cycle regulated
In gel shift assays using E2F(a) probe and nuclear extract from quiescent T98G cells (G 0 -T98), E2F complexes were supershifted with antibody to either E2F4 or p130 (Figure 4b ). However, when the probe was incubated with nuclear extract from serumstimulated T98G cells (G 1 /S-T98G cells), the complexes were supershifted with antibody to either E2F1 or E2F4, but not with antibody to p130. The results obtained with the E2F(a) probe were quite similar to the results obtained with the cE2F probe (Figure 4a ). When E2F(b) probe was incubated with nuclear extract from G 0 -, G 1 /S-T98G cells, the DNA-protein complexes were supershifted with antibody to E2F1 and E2F4 ( Figure 4c ). In contrast, however, to the results obtained with the cE2F and E2F(a) probes, p130 was not detectable in DNA-protein complexes generated when E2F(b) was incubated with nuclear extract from G 0 -T98G cells. A longer probe containing the E2F(b) site at 7103/799 in the p21 promoter that includes ®ve additional base pairs of upstream sequence (GGGCGGCGCG) was also used in gel shift analysis. The results obtained with this probe and nuclear extract from G 0 -, G 1 /S-T98G cells were essentially identical to the results obtained with the E2F(b) probe (data not shown). Additional gel shift assays using nuclear extracts from G 0 -and G 1 /S-NIH3T3 cells and the E2F(b), E2F(c) and cE2F probes gave similar results to that observed when using nuclear extracts from G 0 -and G 1 /S-T98G cells (data not shown).
Role of E2F(a) and E2F(b) in the induction of human p21 gene
We next investigated the role of these E2F binding sites in the induction of the p21 gene. Using the 7215/+1 region of the human p21 gene, we made several promoter reporter constructs containing various deletions that remove either the upstream E2F(a) motif or the E2F(b) and Sp1 motifs ( Figure 5a ). U343 cells were cotransfected with each of the p21 reporter constructs along with pCMV-E2F1 and pCMV-DP1 expression vectors. As shown in Figure  5b , luciferase activity increased 4.8-fold over that observed in the absence of pCMV-E2F1/pCMV-DP1 (designated control) in cells transfected with 7215 luc. Increases in luciferase activity were observed also in transfections with 7132 luc (4.0-fold) and 7132(d30-1) luc (5.8-fold) over their corresponding control values. Notably, basal and E2F1-induced levels of luciferase activity in cells transfected with 7215 luc, 7132 luc and 7132(d30-1) luc were similar. Taken together with the absence of the upstream E2F(a) site in 7132 luc and 7132(d30-1) luc, these data suggest E2F1 can transactivate the p21 promoter through one or more of the downstream E2F(b) sites. Surprisingly, very little, if any, increases in luciferase activity were observed in cells transfected with either 7215(d112-65) luc or785 luc. The gel shift analysis in Figure 4 demonstrates, however, that E2F1 protein present in G 1 /S nuclear extracts can bind either the E2F(a) or E2F(b) sites and presumably transactivate the gene. The interpretation of these results is that elements within the 7118 to 785 region of the p21 gene potentiate E2F1 transactivation through the E2F(a) site and possibly the E2F(b) site at 736 to 732. In contrast to the transactivation observed with E2F1, there was no signi®cant induction in luciferase activity over the corresponding control value when p21 gene may be attributed to the subcellular localization of E2F4 (Lindeman et al., 1997) . In this regard, it has recently been shown that overexpressed E2F4 is concentrated mainly in the cytoplasm. This is in marked contrast to E2F1, which is constitutionally nuclear (Magae et al., 1996) .
Elements within the 7215/+1 region of the p21 promoter are important for increases in promoter activity at the G 1 /S boundary
We investigated the importance of the E2F(a) and E2F(b) sites in conferring cell cycle-dependent regulation to the p21 promoter. After cotransfection of 7215 luc or 7132 luc or 785 luc constructs, T98G cells were made quiescence by serum starvation, restimulated with serum and then harvested at dierent time points. Luciferase activity from the 7215 luc and 7132 luc constructs was ®rst detected at similar levels in serum-starved and quiescence cells, then increased rapidly up until 4 h serum-stimulation, but then gradually declined up until 8 h serum-stimulation ( Figure 6a ). In contrast, the 785 luc constuct, which lacks both the E2F(a) and E2F(b) sites (7103/785), showed no luciferase activity in quiescent or serumstimulated cells. The early induction of luciferase activity (up until 4 h) from the 7215 luc and 7132 luc p21 promoter constructs corresponds to previous observations showing the endogenous p21 gene is rapidly activated in cells restimulated with serum (Liu et al., 1996; Michieli et al., 1994) . Mitogenic factors present in serum induce expression of immediate-early genes, including members of the Egr family, that stimulate reentry into the cell cycle (Lau and Nathans, 1991) . In this regard, Egr1, an immediate-early transcription factor which binds GC-rich motifs, regulates expression of the TK promoter during the G 0 /G 1 transition (Molnar et al., 1994) . In an analogous manner, the p21 gene through its GC-rich region (7132 to 785) may be transiently induced by a member of the Egr family. Rapid increases in luciferase activities from 7215 luc and 7132 luc were again observed up until 12 h serum-stimulation. However, whereas luciferase activity from 7215 luc continued to increase up until 20 h, activity from 7132 luc reached a plateau after 12 h (Figure 6a ). In our Western blotting analysis, an increase in endogenous E2F1 protein was detectable 12 h after serum-stimulation and continued to increase up until 20 h whereas the induction of endogenous p21 protein was ®rst detected after 16 h and continued to increase up until 20 h (Figure 6b ). In contrast to the level of E2F1 protein, which only began to increase at the late G 1 , the level of E2F4 protein remained constant throughout the cell cycle. Flow cytometry analysis indicated that for T98G cells, late G 1 , G 1 /S boundary and early S-phase occurs 12, 16 and 20 h, respectively, after serum stimulation (Figure 6c ) (Mayol et al., 1995) . We showed in our gel shift assays using nuclear extract from T98G cells that at the G 1 /S boundary the E2F(a) site is occupied by E2F1 or E2F4 complexes (Figure 4b ). Considering that endogenous E2F1 protein levels are increasing at the G 1 /S boundary, the results in Figure 6a , suggest that in addition to the E2F(b) site(s) being important for cell cycle-dependent induction of the p21 gene the E2F(a) Figure 1a ). Several genes involved in cell cycle progression including the ornithine decarboxylase (ODC) genes (Bello-Fernandez et al., 1993) and the prothymosin a gene (Gaubatz et al., 1994) required for cells to progress through G 1 to S-phase (Kelly, 1986; Marcu et al., 1992) , through an E-box element. In addition, serum-induced stimulation of the gene encoding a pyrimidine biosynthetic enzyme, carbamoyl-phosphate synthase/aspartate carbamoyltransferase/dihydroorotase (cad) at G 1 /S-phase boundary, is mediated by an E-box motif and cooperates with E2F-like motifs to achieve cell cycle progression (Miltenberger et al., 1996) . It is likely, then, that the Ebox element at 7161/7156 contributes to the transactivation of the p21 promoter at the G 1 /S phase boundary in a cooperative manner with E2F(a) site.
Discussion
In our studies we have identi®ed and characterized E2F binding sites within the 7215/+1 region of the human promoter that mediate basal levels of p21 in G 0 cells and increases in p21 levels at the G 1 /S boundary. A hypothetical model for cell cycle-dependent regulation of the p21 gene through these E2F binding sites is shown in Figure 7 . In quiescence cells, an association between an E2F4/p130 complex and the upstream E2F(a) site in the p21 promoter is observed. Interestingly, this E2F4/p130 complex does not appear to in¯uence transcriptional regulation of the p21 gene in quiescent cells. In contrast, the downstream E2F(b) and possibly the Sp1 sites in the 7118/ 785 region of the gene likely contribute to maintaining basal transcription of the p21 gene in G 0 cells. It has recently been shown in cells arrested in G 0 or early G 1 that the majority of E2F4 protein localizes to the nucleus. However, with progression toward S-phase E2F4 protein relocalizes to the cytoplasm (Lindeman et al., 1997) . These observations suggest that the`free' E2F4 protein that is localized to the nucleus of G 0 cells can act through the E2F(b) site and contribute to maintenance of basal p21 promoter activity in the G 0 phase (`basal activity of p21'). This hypothesis is supported by the recent observation demonstrating that nuclear localization of E2F4 correlates with its transcriptional activity (Lindeman et al., 1997) . As cells reenter the cell cycle and reach the late G 1 phase, newly synthesized E2F1 in the absence of associated pRb is able to bind the E2F(b) sites (7118/785 and possibly 736/732). Several recent reports have shown that Sp1 and E2F1 protein, but not E2F4 or E2F5, can physically interact and cooperate in the transactivation of genes containing consensus Sp1 and E2F binding sites (Lin et al., 1996; Karlseder et al., 1996) . The association between E2F1 and Sp1 proteins has been shown to be speci®c to cells in mid-to late G 1 phase (Lin et al., 1996) . A similar spatial organization of E2F and Sp1 binding sites is present and conserved between the human and mouse p21 promoters ( Figure  1a) . It is possible, therefore, that E2F1 can transactivate the p21 gene in a cooperative manner with Sp1 protein (`mid-late G 1 induction of p21'). Newly synthesized E2F1 is also able to bind to the E2F(a) site and transactivate the p21 gene; however, transactivation through these sites is insuucient and other sequences such as the E-box element (7161/ CAGCTG/7156), which binds c-Myc protein at the G 1 /S boundary, is necessary for achieving cell cycle progression (`G 1 /S boundary induction of p21') (Miltenberger et al., 1996) . The increased levels of p21 protein observed in T98G cells during the G 1 /S transition are presumably required in order to coordinate and form a stable and active cyclin/cdk/p21 complex that allows the cells to continue to negotiate S-phase. In support of this, we have shown previously that ectopic expression of cyclin D1 correlated with increased levels of p21 protein, which did not lead to growth arrest (Hiyama et al., 1997) . Moreover, a recent study has demonstrated that p21 protein is required for assembly of cdk4/cyclin D1 complexes . These ®ndings are remarkable in light of the extensive body of evidence indicating that p21 can inhibit E2F-dependent transcription of several growth-related genes (DHFR, cdc2, SV/E2F and E2F-1) and disrupt E2F/cdk2/p107 and E2F/cdk2/p130 complexes (Dimri et al., 1996; Shiyanov et al., 1996; Zhu et al., 1995b) . Taken together, these results suggest that E2F is a target and ultimate eector of p21 action and p21-mediated disruption of the cdk2-bound complex would prevent activation of E2F (Dimri et al., 1996; Shiyanov et al., 1996; Zhu et al., 1995b) . Thus, the activation of the p21 gene by E2F and the inactivation of E2F transactivation activity by p21 protein provides a feedback loop for these two molecules with apparently opposing activities. The feedback repression of E2F activity by p21 may be important for limiting accumulation of S-phase promoting activities and allowing progression through the cell cycle by resetting the regulatory components that govern the transition through the G 1 phase.
Although we did not construct analogous promoter deletion constructs for the mouse p21 promoter, the high degree of conservation in E2F binding sites shared between the mouse and human promoters and the essentially identical pattern of binding of nuclear extract-derived proteins observed with the E2F(a), E2F(b) and E2F(c) probes suggest E2F also regulates expression of the mouse p21 gene. The ®nding that human and mouse genes contain E2F binding sites, suggests that when expression of E2F is deregulated p21 gene expression may also be deregulated. The unchecked cell cycle progression which occurs in tumor cells is a situation where expression of E2F can be deregulated. Indeed, our ®ndings demonstrating that E2F transactivates the p21 promoter provide a plausible explanation for the high levels of p21 protein observed in several dierent human tumors (Jung et al., 1995; Marchetti et al., 1996) in which elevated p21 levels may play a regulatory role in stabilization of cell cycle progression . This study highlights a potential novel aspect of p21 activity in the cell cycle machinery.
Material and methods
Cell culture and synchronization
Human U343 and T98G glioma cells were grown in Dulbecco's modi®ed Eagle's medium (DMEM) (Mediatech) supplemented with 10% fetal calf serum (FCS). The status of the p53 gene has previously been shown to be wild-type in U343 cells (Hiyama et al., 1997) , but mutated in T98G cells (Ullrich et al., 1992) . For synchronization experiments, T98G cells were serum-starved for 3 days by culturing in MCDB-105 serum-free medium (Sigma) and then stimulated into synchronous cell cycle progression by changing the medium to DMEM containing 10% FCS (Mayol et al., 1995) .
Nuclear extracts and gel mobility shift analysis
Subcon¯uent cells in 100 mm dishes were washed with phosphate buered saline (PBS) and resuspended in 400 ml of hypotonic buer [10 mM HEPES, pH 7.9, 10 mM KCI, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM dithiothreitol (DTT), 0.5 mM phenylmethylsulfonyl¯uoride (PMSF), 1 mg/ml pepstatin, 10 mg/ml leupeptin, 10 mg/ml aprotinin, 1 mM sodium orthovanadate (NaVO 4 )] and incubate at 48C for 15 min. The cells were lysed by adding 25 ml of 5% Nonipet P-40 and vortexing. Nuclei were pelleted (8000 g for 30 s) and resuspended in 50 ml of hypertonic buer (20 mM HEPES, pH 7.9, 400 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 1 mM PMSF, 1 mg/ml pepstatin, 10 mg/ml leupeptin, 10 mg/ml aprotinin, 1 mM NaVO 4 ). After thorough mixing on a rotating wheel at 48C for 15 min, the suspension was centrifuged at 15 000 g for 5 min. The supernatant was used as nuclear extract for the gel mobility shift assay. For gel mobility shift experiment, oligonucleotides containing the desired E2F binding site were synthesized, annealed to each other, and labeled using T4 polynucleotide kinase. The DNA-protein binding reactions were carried out in a 20 ml reaction mixture containing 10 mM HEPES, pH 7.9, 10% glycerol, 50 mM KCl, 0.1 mM EDTA, 0.3 mM DTT, 1 mM KPO 4 , 1.5 mg of sonicated herring sperm DNA and 200 pg of 32 P-labeled DNA probe and 2.0 ml of nuclear extract. Mixtures were ®rst incubated on ice for 30 min in the absence of the labeled probe and then for 30 min at room temperature in the presence of the labeled probe. The gel shift assay with puri®ed recombinant E2F proteins contained 5 ± 10 ng each E2F1 and GST-DP1 (Dynlacht et al., 1994) and sonicated herring sperm DNA was omitted from reactions. For competition experiments, 2 or 20 ng of cold oligonucleotide was mixed with the labeled probe before addition of nuclear extract. Reaction products were separated on 4% acrylamide gels by electrophoreses in 0.256TBE for 2 h at 48C at 180 V.
In supershift experiments, nuclear extracts were preincubated with 1 to 2 ml of high concentration antibody in binding buer (in the absence of sonicated herring sperm DNA) for 1 h on ice prior to initiation of the binding assay. The antibodies were anti-human pRb XZ77, anti-p107 SD9, anti-p130 C-20 (Santa Cruz Biotechnology), anti-human E2F1 KH20, anti-E2F1 C-20 (Santa Cruz Biotechnology), anti-E2F4 WWF11, anti-FLAG M1 (IBI).
Plasmids
The deletion series of p21 promoter-luciferase constructs were generated by Polymerase Chain Reaction (PCR) using 7215 luc (7215 to +1 region of the human promoter; kindly provided by L Freedman) as template and oligonucleotide primer pairs the generate the indicated deletions. PCR-generated fragments were cloned in the pGL2 vector (Promega). DNA sequencing was performed for each plasmid to verify that misincorporation had not occurred during the PCR ampli®cation reaction.
Luciferase assay
5610
5 U343 cells were seeded into 100 mm dishes with DMEM media containing 10% FCS. Twenty-four hours later, cells were cotransfected with 5 mg of the 7215 luc or 7215(d112 ± 65) luc or 7132 luc or 7132(d30 ± 1) luc or 785 luc promoter construct, 2.5 mg each of pCMV-E2F1/ pCMV-DP1 or pCMV-E2F4/pCMV-DP1, and 3 mg of RSV-CAT plasmid DNA using the calcium phosphate method (Pear et al., 1993) . After 12 h, cells were washed twice with PBS and then incubated for 36 h in DMEM containing 10% FCS. Cell lysates were collected and assayed for luciferase and chloramphenicol acetyltransferase (CAT) activities as described previously (Hiyama et al., 1997) .
To examine the activation of the p21 promoter with cell cycle progression, T98G cells were cotransfected with 5 mg of the 7215 luc or 7132 luc or 785 luc promoter construct and 3 mg of RSV-CAT. After the transfection, cells were brought to quiescence as described above and then harvested for luciferase assays at 4 h intervals after serum-stimulation.
Western blotting
Total cell extracts from T98G cells were prepared by washing with PBS and then homogenization in lysis buer (1% SDS, 10 mM Tris-HCl, pH 7.4). Extracts were boiled for 5 min and centrifuged at 15 000 g for 10 min after DNA shearing by multiple syringe passages. Protein concentration were determined using the DC Protein Assay (Bio-Rad, Hermes, CA). Equal amounts of lysate (50 mg) were boiled for 4 min in SDS-sample buer and subjected to 12.5% SDS ± PAGE and then transferred to nitrocellulose membranes (Bio-Rad). The membrane was blocked in 5% nonfat dried milk in TN-Tween buer (25 mM Tris-HCl pH 7.5, 200 mM NaCl, 0.2% Tween-20) for 30 min and then incubated with either anti-E2F1 antibody C-20 (Santa Cruz Biotechnology) or anti-E2F4 antibody WWF11, in the same buer for 1 h at room temperature. After washing in TN-Tween buer, the ®lters were incubated with horseradish peroxidase-conjugated goat anti-rabbit IgG antibody (Vector Laboratories Inc., Burlingame, CA). Protein were detected with ECL detection reagents (Amersham).
Cell cycle analysis
Cells were trypsinized, collected and washed with PBS. Cell pellets were resuspended in 1 ml PBS and ®xed in 7 ml of 70% ethanol and stored at 7208C. On the day of analysis, cells were collected by centrifugation and washed with PBS. Cell pellets were resuspended with PBS containing 200 mg/ml of RNase A and then incubated for 30 min at 378C. DNA was stained with 20 mg/ml of propidium iodide and¯ow cytometry analysis was performed by FACScan (Becton-Dickinson) according to the manufacturer's procedure.
